 Connection
Jens Kuhn to Young Adult
This is a "connection" page, showing publications Jens Kuhn has written about Young Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.287 |
|
|
|
-
Schüller CB, Wagner BJ, Schüller T, Baldermann JC, Huys D, Kerner Auch Koerner J, Niessen E, Münchau A, Brandt V, Peters J, Kuhn J. Temporal discounting in adolescents and adults with Tourette syndrome. PLoS One. 2021; 16(6):e0253620.
Score: 0.052
-
Schüller T, Gruendler TOJ, Huster R, Baldermann JC, Huys D, Ullsperger M, Kuhn J. Altered electrophysiological correlates of motor inhibition and performance monitoring in Tourette's syndrome. Clin Neurophysiol. 2018 09; 129(9):1866-1872.
Score: 0.042
-
Hartfiel C, Bodatsch M, Klosterkötter J, Kuhn J. [Establishment of an Animal Based Therapy at a University Hospital for Psychiatry: Results of a Preliminary Study and Future Prospects]. Psychiatr Prax. 2017 Jan; 44(1):36-40.
Score: 0.035
-
Huys D, Bartsch C, Koester P, Lenartz D, Maarouf M, Daumann J, Mai JK, Klosterkötter J, Hunsche S, Visser-Vandewalle V, Woopen C, Timmermann L, Sturm V, Kuhn J. Motor Improvement and Emotional Stabilization in Patients With Tourette Syndrome After Deep Brain Stimulation of the Ventral Anterior and Ventrolateral Motor Part of the Thalamus. Biol Psychiatry. 2016 Mar 01; 79(5):392-401.
Score: 0.032
-
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, Lhomme E. Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. PLoS Negl Trop Dis. 2026 Jan; 20(1):e0013950.
Score: 0.018
-
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA. Vector-Induced Humoral Responses After rVSV?G-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies. J Infect Dis. 2025 Oct 15; 232(4):1004-1014.
Score: 0.018
-
Baldermann JC, Petry-Schmelzer JN, Schüller T, Mahfoud L, Brandt GA, Dembek TA, van der Linden C, Krauss JK, Szejko N, Müller-Vahl KR, Ganos C, Al-Fatly B, Heiden P, Servello D, Galbiati T, Johnson KA, Butson CR, Okun MS, Andrade P, Domschke K, Fink GR, Fox MD, Horn A, Kuhn J, Visser-Vandewalle V, Barbe MT. A critical role of action-related functional networks in Gilles de la Tourette syndrome. Nat Commun. 2024 12 16; 15(1):10687.
Score: 0.017
-
Valayer S, Alexandre M, Prague M, Beavogui AH, Doumbia S, Kieh M, Greenwood B, Leigh B, Poupelin M, Schwimmer C, Sow SO, Berry IM, Kuhn JH, Fusco D, Cauwelaert ND, Watson-Jones D, Thiébaut R, Lévy Y, Yazdanpanah Y, Richert L, Lhomme E. Evaluation of waning of IgG antibody responses after rVSV?G-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial. Emerg Microbes Infect. 2025 Dec; 14(1):0.
Score: 0.017
-
Davey RT, Collins GL, Rouphael N, Poliquin G, McConnell R, Grubbs G, Moir SL, Langley JM, Teitelbaum M, Hewlett AL, McLellan SLF, Bhadelia N, Raabe VN, Mulligan MJ, Maljkovic Berry I, Dighero-Kemp B, Kurtz JR, Hensley LE, Dozier NCE, Marron LCB, DuChene A, Kuhn JH, Brown SK, Khurana S, Lane HC, Neaton JD. Safety and immunogenicity of a delayed booster dose of the rVSV?G-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial. Lancet Microbe. 2024 11; 5(11):100923.
Score: 0.016
-
Schüller T, Huys D, Kohl S, Visser-Vandewalle V, Dembek TA, Kuhn J, Baldermann JC, Smith EE. Thalamic deep brain stimulation for tourette syndrome increases cortical beta activity. Brain Stimul. 2024 Mar-Apr; 17(2):197-201.
Score: 0.016
-
Martínez VP, Di Paola N, Alonso DO, Pérez-Sautu U, Bellomo CM, Iglesias AA, Coelho RM, López B, Periolo N, Larson PA, Nagle ER, Chitty JA, Pratt CB, Díaz J, Cisterna D, Campos J, Sharma H, Dighero-Kemp B, Biondo E, Lewis L, Anselmo C, Olivera CP, Pontoriero F, Lavarra E, Kuhn JH, Strella T, Edelstein A, Burgos MI, Kaler M, Rubinstein A, Kugelman JR, Sanchez-Lockhart M, Perandones C, Palacios G. "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina. N Engl J Med. 2020 12 03; 383(23):2230-2241.
Score: 0.013
-
Li N, Baldermann JC, Kibleur A, Treu S, Akram H, Elias GJB, Boutet A, Lozano AM, Al-Fatly B, Strange B, Barcia JA, Zrinzo L, Joyce E, Chabardes S, Visser-Vandewalle V, Polosan M, Kuhn J, Kühn AA, Horn A. A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder. Nat Commun. 2020 07 03; 11(1):3364.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|